GCLM
GCLM (glutamate-cysteine ligase modifier subunit, also known as GLCLR) is the light regulatory subunit of glutamate-cysteine ligase, the first rate-limiting enzyme of glutathione synthesis. It partners with a heavy catalytic subunit to form the functional enzyme. Browse Assay Genie's current range of GCLM research reagents below, or read on for the biology behind the target.
Glutamate-cysteine ligase, also known as gamma-glutamylcysteine synthetase, is the first rate-limiting enzyme of glutathione synthesis. The enzyme consists of two subunits: a heavy catalytic subunit and a light regulatory subunit. GCLM is the light regulatory subunit, so it is the component that modifies the activity of the holoenzyme rather than the one that carries the catalytic role. Researchers studying glutathione biosynthesis therefore often examine GCLM alongside its catalytic partner.
The human GCLM gene encodes a protein listed in UniProt as glutamate--cysteine ligase regulatory subunit. HGNC places it in the gene group of glutamate-cysteine ligase subunits, and UniProt assigns it to the glutamate--cysteine ligase light chain subfamily. Alternative splicing of the GCLM gene produces multiple transcript variants that encode different isoforms. Orthologues are named Gclm in both mouse and rat, which allows the gene to be studied in rodent models.
The gene has been known by the alias GLCLR and by the previous name glutamate-cysteine ligase, modifier subunit. In terms of disease relevance, the NCBI Gene summary notes that gamma-glutamylcysteine synthetase deficiency has been implicated in some forms of haemolytic anaemia. This links the glutamate-cysteine ligase pathway, and by extension its subunits, to red blood cell biology. Any GCLM antibody, GCLM ELISA kit or recombinant GCLM protein is used to investigate this regulatory component of glutathione production.
GCLM is the regulatory subunit of the first rate-limiting enzyme in glutathione synthesis, making it central to studies of this pathway.
The enzyme comprises a heavy catalytic and a light regulatory subunit, so GCLM is relevant to work on how the two subunits function together.
Gamma-glutamylcysteine synthetase deficiency has been implicated in some forms of haemolytic anaemia, giving GCLM relevance to related disease studies.
Alternative splicing yields multiple transcript variants encoding different isoforms, which makes GCLM a subject for isoform-focused investigation.
GCLM is the light regulatory subunit of glutamate-cysteine ligase, also called gamma-glutamylcysteine synthetase. This enzyme catalyses the first rate-limiting step of glutathione synthesis. It works together with a heavy catalytic subunit, with GCLM providing the regulatory component of the two-subunit enzyme.
GCLM has the alias GLCLR and the previous name glutamate-cysteine ligase, modifier subunit. UniProt lists the protein as glutamate--cysteine ligase regulatory subunit. Alternative splicing produces multiple transcript variants that encode different isoforms, so check which isoform is relevant to your work.
Mouse and rat both have a Gclm orthologue, so the gene can be studied in rodent systems; check the datasheet of any product for its validated reactivity. NCBI notes that gamma-glutamylcysteine synthetase deficiency has been implicated in some forms of haemolytic anaemia.
Other glutathione pathway enzymes and glutamate-cysteine ligase partners that may be of interest alongside GCLM.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P48507; product specifications from Assay Genie datasheets.